A new research paper showing how a comprehensive ulcer prevention programme which included the use of ALLEVYN◊ LIFE can significantly decrease hospital-acquired pressure ulcers (HAPUs).1
The study was conducted in an adult intensive care unit (ICU) at Eskenazi Health, Indianapolis, Indiana, US, between 2012 and 2013, and published in the American Journal of Critical-Care Nurses.
The research emphasises that hospitals who adopt a standardised protocol for the prevention and treatment of HAPUs may see potential cost benefit of such prevention. At the end of the first year, the prevention programme demonstrated a 69% decrease in HAPUs.1 The estimated potential cost saving for the Eskenazi Health ICU was nearly $1 million, and the convincing results in the ICU have led to the approval of a hospital-wide rollout of the HAPU prevention programme. 1
ALLEVYN LIFE, a silicone foam dressing also indicated for the treatment and prevention of pressure ulcers, developed by Smith & Nephew, was introduced to the protocol as part of the standard prevention method three months into the programme.
Rachel Culpepper, Registered Nurse at Eskenazi Health stated, “This study validates the need for a comprehensive, proactive, collaborative prevention programme in hospitals. Although it is difficult to isolate the effects of individual programme components, silicone foam dressings can complement an existing pressure ulcer prevention programme, and are believed to contribute to the reduction in HAPUs.”
Additional components to the HAPU prevention programme include educating Eskenazi Health staff members and a focus on adherence to protocols for patient care. Both have proven to be part of an effective programme for reducing the incidence of HAPUs in the ICU, according to the study results.1
Read more about ALLEVYN LIFE
1. Swafford K, Culpepper R, Dunn C. Use of a Comprehensive Program to Reduce the Incidence of Hospital-Acquired Pressure Ulcers in an Intensive Care Unit. Am J Crit Care. 2016 Mar;25(2):152-5